$2.75
Today
as of Aug 5, 16:46 ET
Last 30 days
Recent Press Releases & News
BioLineRx and Hemispherian AS to Present Data Demonstrating Strong Synergy of GLIX1 with PARP Inhibitors in HR-Proficient Ovarian Cancers at ESMO 2026
BioLineRx and Hemispherian Announce New Preclinical Data Demonstrating Strong Synergistic Effect between GLIX1 and PARP Inhibitor in a Patient-Derived Ovarian Cancer Xenograft Model
Overview
52-week range
$2.15
$6.59
13% of range
Avg surprise (last 2)
+39.9%
Avg reaction (last 2)
+3.6%
100% positive
Latest IV / EM
939%
EM ±184.0% · $3 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Wed May 27, 2026 | Mar/2026 | $-0.36 | — | — | -125.9% | +6.6% | earnings |
| Thu Aug 14, 2025 | Jun/2025 | $1.00 | $-0.35 | -185.7% | — | — | earnings |
| Tue May 27, 2025 | Mar/2025 | $1.39 | $-0.84 | +265.5% | — | +0.5% | earnings |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Thu Aug 13, 2026 | Jun/2026 | OTHER | $0.00 | $1.00 | -100.0% |